Research Guide

Peptides for Metabolic Research: A Research Overview

The science of metabolic peptides has advanced significantly in the past decade. Researchers now have access to a spectrum of compounds that modulate energy expenditure, insulin sensitivity, and fat metabolism through distinct but complementary mechanisms. This guide summarises key research-grade peptides studied in the metabolic health context.

The Incretin Research Landscape

Glucagon-like peptide-1 (GLP-1) is a naturally occurring incretin hormone that regulates appetite, insulin secretion, and gastric emptying. Decades of academic research into GLP-1 physiology have informed the development of several investigational peptide compounds that target related receptor systems. Understanding these receptor pathways is foundational to metabolic peptide research.

Retatrutide — View Research →

Retatrutide: Triple Receptor Agonism

Retatrutide (LY3437943) is an investigational peptide currently in Phase 3 clinical trials that simultaneously activates GLP-1, GIP, and glucagon receptors. Glucagon receptor agonism increases resting energy expenditure and promotes hepatic fat oxidation — mechanisms that distinguish it from earlier single and dual-receptor compounds. Phase 2 data (Jastreboff et al., NEJM 2023) demonstrated significant effects on body weight and metabolic markers, making it one of the most closely watched compounds in the tri-agonist research pipeline.

MOTS-C — View Research →

MOTS-C: Mitochondrial Metabolic Regulation

MOTS-C operates through a fundamentally different mechanism to incretin-based approaches. As a mitochondria-derived peptide, it activates AMPK to improve insulin sensitivity and metabolic flexibility — effectively mimicking aspects of aerobic exercise at the cellular level. Animal research demonstrates improved glucose utilisation and fat oxidation. MOTS-C's position at the intersection of mitochondrial biology and systemic metabolism makes it a distinct and complementary subject of study.

BPC-157 + TB-600 — View Research →

BPC-157: Metabolic and GI Research

BPC-157, derived from a gastric protective protein, has demonstrated effects on nitric oxide signalling and inflammatory modulation across multiple tissue types in preclinical research. Its gastroprotective properties and influence on metabolic signalling pathways have made it a subject of interest in GI and metabolic research contexts, separate from its primary tissue repair applications.

Conclusion

Metabolic peptide research spans multiple biological systems — from tri-agonist receptor pharmacology to mitochondrial energy signalling. Each compound in this field offers a mechanistically distinct research angle. Aurex Labs formulates research-grade versions of investigational compounds for use in qualified research settings.

Research-Grade Formulations

All compounds available in pen or vial format. Order directly via WhatsApp or Telegram.

Shop All Products →Research Catalogue

For research purposes only. This page does not constitute medical advice. Consult a qualified healthcare professional before use.

Your Order

Your cart is empty.